112 related articles for article (PubMed ID: 2353604)
1. [Changes in immunoparameters following cryosurgery in prostate cancer].
Fukagai T; Tazawa K; Higaki Y; Imamura K
Hinyokika Kiyo; 1990 Mar; 36(3):307-17. PubMed ID: 2353604
[TBL] [Abstract][Full Text] [Related]
2. Alterations in host responsiveness in patients with prostatic cancer following cryosurgery or transurethral resection.
Ablin RJ; Bruns GR; Guinan PD; Sadoughi N; Sheik HA; Bush IM
Am Surg; 1977 Mar; 43(3):144-50. PubMed ID: 320926
[TBL] [Abstract][Full Text] [Related]
3. Analysis of NK cell activity, lymphocyte reactivity to mitogens and serotest PSA and TPS values in patients with primary and disseminated prostate cancer, PIN and BPH.
Kastelan M; Kovacić K; Tarle R; Kraljić I; Tarle M
Anticancer Res; 1997; 17(3B):1671-5. PubMed ID: 9179216
[TBL] [Abstract][Full Text] [Related]
4. [Changes in tumor markers following cryosurgery of prostate carcinoma].
Higaki Y; Imamura K
Hinyokika Kiyo; 1989 Feb; 35(2):265-70. PubMed ID: 2472049
[TBL] [Abstract][Full Text] [Related]
5. Total cryosurgery of the prostate versus standard cryosurgery versus radical prostatectomy: comparison of early results and the role of transurethral resection in cryosurgery.
Gould RS
J Urol; 1999 Nov; 162(5):1653-7. PubMed ID: 10524891
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. II. Effect of oestrogen, cryosurgery and transurethral resection on thymic-dependent lymphocytic blastogenesis.
Ablin RJ; Guinan PD; Bruns GR; Sheik HI; Sadoughi N; Bush IM
Urol Int; 1976; 31(5):383-400. PubMed ID: 1087494
[TBL] [Abstract][Full Text] [Related]
7. [Clinical studies of transurethral resection in patients with benign prostatic hypertrophy].
Nakajima H; Mori K; Ohnishi S; Kato S; Tanda H
Hinyokika Kiyo; 1988 Aug; 34(8):1411-4. PubMed ID: 2461645
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cell activity of prostatic cancer patients.
Choe BK; Frost P; Morrison MK; Rose NR
Cancer Invest; 1987; 5(4):285-91. PubMed ID: 2444316
[TBL] [Abstract][Full Text] [Related]
9. [Prostatic cancer developing after transurethral resection of the prostate for benign prostatic hyperplasia].
Tanaka Y; Aoyama H; Momose H; Ono T; Samma S; Tanaka N; Akiyama T; Tani Y; Masuda Y; Matsuki H; Tani M; Tanaka M
Hinyokika Kiyo; 2001 Jan; 47(1):11-4. PubMed ID: 11235214
[TBL] [Abstract][Full Text] [Related]
10. [Clinical study on prostatic cancer detected incidentally by transurethral resection of the prostate].
Hayakawa T; Mitsuya H; Kojima M; Hayase Y
Hinyokika Kiyo; 2002 Jan; 48(1):13-6. PubMed ID: 11868378
[TBL] [Abstract][Full Text] [Related]
11. [Usefulness of transurethral resection in cancer of the prostate].
Rodríguez JV; Chechile G
Arch Esp Urol; 1989; 42 Suppl 2():165-77. PubMed ID: 2639620
[TBL] [Abstract][Full Text] [Related]
12. Increased serum total creatine kinase and creatine kinase isoenzyme MB after cryosurgical ablation of the prostate.
Long JP; Fallick ML; Rand W
J Urol; 1997 May; 157(5):1723-6. PubMed ID: 9112513
[TBL] [Abstract][Full Text] [Related]
13. Cryosurgery of prostate cancer. Use of adjuvant hormonal therapy and temperature monitoring--A one year follow-up.
Lee F; Bahn DK; McHugh TA; Kumar AA; Badalament RA
Anticancer Res; 1997; 17(3A):1511-5. PubMed ID: 9179188
[TBL] [Abstract][Full Text] [Related]
14. [The results of transurethral resection of the prostate].
Nakajima Y; Nakamura S; Kimura S
Hinyokika Kiyo; 1988 Sep; 34(9):1607-11. PubMed ID: 2463750
[TBL] [Abstract][Full Text] [Related]
15. [Metastatic liver tumor arising from prostate cancer following transurethral resection of the prostate--a report of two cases].
Yamamoto N; Zhang X; Soramoto S; Kuroda I; Ueda N; Yamashita M; Takenaka I
Gan To Kagaku Ryoho; 2001 Apr; 28(4):545-8. PubMed ID: 11329793
[TBL] [Abstract][Full Text] [Related]
16. Use of second treatment following definitive local therapy for prostate cancer: data from the caPSURE database.
Grossfeld GD; Stier DM; Flanders SC; Henning JM; Schonfeld W; Warolin K; Carroll PR
J Urol; 1998 Oct; 160(4):1398-404. PubMed ID: 9751363
[TBL] [Abstract][Full Text] [Related]
17. Correlation of cell proliferation marker (TPS), natural killer (NK) activity and tumor load serotest (PSA) in untreated and treated prostatic tumors.
Tarle M; Kovacić K; Kastelan M
Anticancer Res; 1993; 13(1):215-8. PubMed ID: 7682800
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of cryosurgical ablation of prostate cancer: the University of California, San Francisco experience.
Koppie TM; Shinohara K; Grossfeld GD; Presti JC; Carroll PR
J Urol; 1999 Aug; 162(2):427-32. PubMed ID: 10411051
[TBL] [Abstract][Full Text] [Related]
19. Transurethral resection in prostatic cancer.
Fujita K; Kimura T; Saito K; Sangen H; Furuhata T; Uyama K; Ogura K; Ueno F
Clin Ther; 1988; 10 Spec No():12-5. PubMed ID: 2466566
[TBL] [Abstract][Full Text] [Related]
20. [Results of transurethral resection of prostate plus incision (TUR-P+I) for benign prostatic hypertrophy].
Ishizaka K; Ohtsuka Y; Nagamatsu H; Fukui I; Oshima H
Hinyokika Kiyo; 1996 Mar; 42(3):207-11. PubMed ID: 8619390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
